Page last updated: 2024-08-26

nicotine and mdl 100907

nicotine has been researched along with mdl 100907 in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (53.85)29.6817
2010's6 (46.15)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giordanetto, F; Leach, AG; Zachariae, U1
Baviera, M; Calcagno, E; Carli, M; Ceglia, I; Invernizzi, RW; Renoldi, G1
Caldwell, DP; Levin, ED; Rezvani, AH1
Filip, M; McCreary, AC; Przegaliński, E; Zaniewska, M1
Greenshaw, AJ; Hayes, DJ; Mosher, TM1
Horton, K; Johnson, M; Levin, ED; Petro, A; Rezvani, AH; Rose, JE; Slade, S; Williams, P1
Filip, M; McCreary, AC; Zaniewska, M1
Filip, M; McCreary, AC; Wydra, K; Zaniewska, M2
Markou, A; Semenova, S1
Fletcher, PJ; Higgins, GA; Lê, AD; Noble, K; Rizos, Z; Silenieks, LB; Soko, AD1
Fletcher, PJ; Guy, EG1
Fletcher, PJ; Higgins, GA; Zeeb, FD1

Other Studies

13 other study(ies) available for nicotine and mdl 100907

ArticleYear
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
    Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14

    Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation

2009
The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
    Journal of neurochemistry, 2004, Volume: 91, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Extracellular Space; Fluorobenzenes; Glutamic Acid; Male; Microdialysis; Nicotine; Piperazines; Piperidines; Potassium Chloride; Prefrontal Cortex; Rats; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tetrodotoxin

2004
Nicotinic-serotonergic drug interactions and attentional performance in rats.
    Psychopharmacology, 2005, Volume: 179, Issue:3

    Topics: Animals; Attention; Dose-Response Relationship, Drug; Drug Interactions; Female; Ketanserin; Nicotine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2005
Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    European journal of pharmacology, 2007, Oct-01, Volume: 571, Issue:2-3

    Topics: Aminopyridines; Amphetamines; Animals; Azepines; Azetidines; Behavior, Animal; Brain; Discrimination, Psychological; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Indoles; Ligands; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Nicotinic; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists

2007
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Behavioural brain research, 2009, Feb-11, Volume: 197, Issue:2

    Topics: Aminopyridines; Amphetamine; Animals; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists

2009
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
    European journal of pharmacology, 2008, Dec-14, Volume: 600, Issue:1-3

    Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ketanserin; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Self Administration; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tobacco Use Disorder

2008
Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
    Synapse (New York, N.Y.), 2009, Volume: 63, Issue:8

    Topics: Aminopyridines; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluorobenzenes; Indoles; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors

2009
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
    Neuropharmacology, 2010, Volume: 58, Issue:7

    Topics: Animals; Antidepressive Agents, Tricyclic; Depression; Imipramine; Male; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome; Swimming; Time Factors; Treatment Outcome

2010
Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:7

    Topics: Aminopyridines; Amphetamines; Animals; Azepines; Ethylamines; Fluorobenzenes; Indoles; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors

2010
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:10

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Brain; Dihydro-beta-Erythroidine; Electrodes, Implanted; Fluorobenzenes; Ganglionic Stimulants; Idazoxan; Male; Nicotine; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Serotonin Antagonists; Substance Withdrawal Syndrome

2010
Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
    Neuropharmacology, 2012, Volume: 62, Issue:7

    Topics: Animals; Ethylamines; Fluorobenzenes; Indoles; Male; Nicotine; Piperidines; Rats; Rats, Long-Evans; Reaction Time; Self Administration; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists

2012
Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
    Pharmacology, biochemistry, and behavior, 2014, Volume: 125

    Topics: Animals; Benzazepines; Conditioning, Classical; Dopamine Antagonists; Ethylamines; Fluorobenzenes; Indoles; Male; Nicotine; Piperidines; Rats, Long-Evans; Reinforcement, Psychology; Salicylamides; Serotonin 5-HT2 Receptor Antagonists

2014
The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    ACS chemical neuroscience, 2015, Jul-15, Volume: 6, Issue:7

    Topics: Aminopyridines; Animals; Benzazepines; Dorsal Raphe Nucleus; Dose-Response Relationship, Drug; Indoles; Male; Medial Forebrain Bundle; Nicotine; Nicotinic Agonists; Rats, Long-Evans; Receptor, Serotonin, 5-HT2C; Reward; Self Stimulation; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists

2015